ECHO Biotech

Echo Biotech is a leading biotechnology company based in Beijing, China, specializing in the research, development, and clinical translation of exosome-based technologies. The company utilizes its proprietary E-Smart platform to engineer extracellular vesicles for targeted drug delivery and therapeutic applications, particularly in oncology and rare diseases. Echo Biotech operates with a dual-track business model, maintaining an internal pipeline of innovative exosome drugs while providing comprehensive CDMO and CRO services to the global life sciences industry. Their service offerings include high-throughput exosome isolation, multi-omics characterization, and large-scale GMP-compliant manufacturing. By integrating advanced bioinformatics with vesicle engineering, the company aims to overcome traditional barriers in drug delivery and precision medicine. Echo Biotech has secured significant funding from prominent investors to accelerate its platform development and pipeline progression.